NSE filing, NSE: PRAMODINI. Summary written from the filing by ALFA Finder's alert engine.
Pramodini Medicare Ltd: key numbers
- Share price
- ₹109.00
- Market cap
- ₹240.3 Cr
- Revenue (annual)
- ₹62.29 Cr
- Net profit (annual)
- ₹17.38 Cr
- P/E (TTM)
- 13.8×Sector 45.8×
- Promoter holding
- 62.64%
- FII holding
- 0.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pramodini Medicare Ltd
All →Pramodini Medicare Management Change
Pramodini Medicare Limited has appointed Mr. Rushikesh Vijay Gosavi as Company Secretary and Compliance Officer, effective 01st November 2025 and 21st March 2026 respectively.
Pramodini Medicare Merger & Restructuring
Pramodini Medicare Limited incorporated a new subsidiary, Sidheart Advanced Healthcare Private Limited, to operate a cardiac facility in Kodagu, Karnataka.
Pramodini Medicare Merger & Restructuring Worth ₹0.03 Cr
Pramodini Medicare Ltd incorporated a new subsidiary, Sidheart Advanced Healthcare Private Ltd, to operate a cardiac facility. The company acquired a 30% stake in the entity.
- Value
- ₹0.03 Cr
Pramodini Medicare Board Meeting Outcome
Pramodini Medicare's board approved forming the SPV Sidheart Advanced Healthcare, buying a Neosoft CT scanner, and appointing an internal auditor. No financial figures were disclosed.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.